DRC and WHO Move Forward on Plans for Phase 3 Ebola Vaccine Trial
The Democratic Republic of the Congo and the World Health Organization are negotiating to accelerate the launch of a multi-armed Phase 3 clinical trial for Ebola vaccines. The trial aims to evaluate multiple vaccine candidates. The talks signify progress in the fight against Ebola outbreaks.
Related stories
Ebola vaccine rollout begins in Democratic Republic of Congo · Infectious disease
HHS Seeks Public Comment on Vaccine Recommendation Categories · Public health
Bausch + Lomb pushes dry eye therapy to Phase 3 after Phase 2 miss · Drug development
Ongoing Ebola Outbreak in Congo Spurs Emergency Response Efforts · Infectious disease
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says.” Browse more stories.